Financial comparisons Bio-Rad Laboratories, Inc.
Equities
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 301.50 USD | +0.65% |
|
+2.66% | -0.49% |
| Jan. 29 | AN2 Therapeutics, Inc. Announces Executive Changes, Effective February 1, 2026 | CI |
| Nov. 26 | US companies step up job cuts amid uncertain economy | RE |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 2.57B | -71.86% | 12.91% | 3.8% | 2.69% | -0.94x | |
| 41.95B | 31.95% | 22.16% | 19.01% | 10.61% | 0.61x | |
| 33.54B | 13.9% | 25.79% | 14.41% | 7.79% | 2.71x | |
| 321B | 0.48% | 1.31% | 246.47% | 2.16% | 0.7x | |
| 21.84B | 7.68% | 25.04% | 16.2% | 7.38% | 3.08x | |
| 5.78B | 23.34% | 38.08% | 20.8% | 21.33% | -1.31x | |
| 25.51B | 4.7% | - | - | - | - | |
| 4.03B | 14.29% | 18.77% | 27.63% | 9.2% | 0.63x | |
| 5.46B | 11.26% | 23.22% | 14.32% | 5.8% | 1.37x | |
| 2.88B | 6.3% | 17.17% | 10.19% | 4.22% | 2.81x | |
| 6.92B | 11.29% | 15.22% | 8.7% | 8.45% | -0.16x | |
| 7.68B | 11.77% | 28.59% | 14.88% | 7.61% | 2.18x | |
| 2.07B | 20.19% | 14.91% | 43.03% | 14.74% | 0.93x | |
| 2.89B | 17.03% | 19.8% | 17.78% | 13.19% | -0.39x | |
| 1.15B | 18.66% | 25.22% | 27.6% | 20.8% | -0.31x | |
| 8.25B | 5.8% | 21.95% | 15.89% | 8.18% | 3.59x | |
| 4B | 10.54% | 21.84% | 18.7% | 11.38% | -1.04x | |
| 2.52B | 4.09% | 6.59% | 10.27% | - | -1.21x | |
| 10.64B | -6.1% | 13.86% | 12.57% | 3.57% | 6.15x | |
| Average | 26.89B | 7.12% | 19.58% | 30.13% | 9.36% | 1.08x | |
| Weighted average by Cap. | 50.33B | 15.32% | 21.38% | 39.69% | 9.44% | 1.19x |
- Stock Market
- Equities
- BIO Stock
- Sector Bio-Rad Laboratories, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
